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ARE SOME NEURONS HYPERSENSITIVE TO METALLIC NANOPARTICLES?

Bobby R. Scott

䊐

Lovelace Respiratory Research Institute

䊐 Engineered metallic nanomaterial particles (MENAP) represent a significant breakthrough in developing new products for use by consumers and industry. Skin application
(e.g., via creams and sprays containing nanoparticles) may provide a key route of potential intake of MENAP and can lead to retrograde transport from nerve endings in the skin to
the somatosensory neurons in dorsal root ganglia (DRG). This paper uses a novel theoretical model (stochastic threshold microdose [STM] model) to characterize survival of
DRG neurons exposed in cell culture replicates to copper nanoparticles, based on published data. Cell death via autophagy is assumed here to occur as a result of the uptake
(called hits) of the nanoparticles by mitochondria. Theoretical results are presented for
the existence of a hypersensitive fraction (about 20%) of neurons that are killed in significant numbers when on average > 1 hit to the at-risk mitochondria occurs. Further, most
hypersensitive neurons appear to be killed by a cumulative exposure of about 2,000 micromolar-hours and the remaining resistant cells may have dysfunctional mitochondria.
Based on these theoretical findings, it is predicted that repeated exposure (e.g., over
years) of the skin of humans to MENAP could lead to significant nervous system damage
and related morbidity.

Keywords: nanoparticle, cytotoxicity, model, in vitro, neurons

INTRODUCTION

Billions of dollars recently have been invested worldwide in nanotechnology research and development (Roco 2005). Metallic and other nanomaterials have properties that make them useful for many applications,
including high conductivity, material strengthening, increasing material
durability, and altering material reactivity. Numerous nanomaterials are
made of metals or metal oxides. The metals include iron, gold, zinc, silver,
copper, lead, cerium, zirconium, cadmium, germanium, and selenium.
Important engineered nanomaterials now in production includes metal
oxides, fullerenes, carbon nanotubes, and quantum dots. Varieties of bionanotechnologies are being developed for biomedical applications.
Nanoparticles also are being researched for possible use in cancer therapy (AshaRani et al. 2009); however, not very much is known about health
risks to nanotechnology workers and the general public from nanoparticles (Donaldson et al. 2004; Hoet et al. 2004; Moghimi et al. 2005;
Oberdörster et al. 2005; Powell and Kanarek 2006a, b; Hoover et al. 2007;
Prabhu et al. 2009).
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Nanoparticles typically are defined as engineered particles having at
least one dimension <100 nanometers (nm). The particles could be
inhaled, ingested, or enter the body via uptake through the skin (intact
or wounded). Potential biological effects include DNA damage, mitochondrial damage, mutations, neoplastic transformation, cell killing, and
related systemic effects (e.g., neurological dysfunctions, heart disease,
and cancer).
The focus of the modeling in this paper is on insoluble engineered
metallic nanomaterial particles (MENAP) made of copper and their cytotoxicity to dorsal root ganglia (DRG) in vitro. Copper nanoparticles are
being manufactured for application in facial spray. Repeated application
of such sprays over long periods could lead to the accumulation of a significant number of copper nanoparticles in nerve cells of the nervous system. Thus, it is important to conduct research related to assessing copper
nanoparticle toxicity to neurons (Prabhu et al. 2009).
Copper is an essential trace mineral that plays an important role in
energy production in the body’s cells. High levels are found in the brain
but are maintained in homeostasis because copper becomes toxic when
in excess and not properly bound (Evans 1973; Sternleib 1980; Prabhu et
al. 2009). Under toxic conditions, copper’s redox reactivity can lead to
the formation of reactive oxygen species (ROS) such as superoxide
anion, hydrogen peroxide, and hydroxyl radical. Excess ROS can lead to
cell damage through oxidative modifications of proteins, lipids, and
nucleic acids, damaging their structures and functions (Halliwell and
Gutteridge 1990; Galhardi et al. 2004; Prabhu et al. 2009).
Concern about the toxicity of copper has led to research in a variety
of areas (Evans 1973; Nalbanadyan. 1983; Saris and Skulskii 1991;
Pourahmad and O’Brien 2000; Cecconi et al. 2002; Gaetke and Chow
2003; Bertinato and L’Abbé 2004; Galhardi et al. 2004; Warheit et al.
2004; Arciello et al. 2005; Oberdörster et al. 2005; Chen et al. 2006, 2007;
Griffitt et al. 2007; Li et al. 2007; Meng et al. 2007a, b; Brain et al. 2009;
Gerloff et al. 2009; Grigg et al. 2009; Monteiro-Riviere and Riviere 2009;
Ruizendaal et al. 2009; VanWinkle et al. 2009). Based on animal studies,
researchers have concluded that the toxicity of copper nanoparticle
depends on particle size, with toxicity increasing with decreasing size
(Chen et al. 2006, 2007). However, this may relate to an appropriate dose metric not being established for characterizing toxicity. Particle number or particle
surface area might be better metrics and would explain why toxicity on
a mass basis has been observed to increase with decreasing particle size.
Surface area and the associated particle solubility in biological media
would provide a metric that would be relevant to the release of copper
ions in or in proximity to target cells. Particle number would be a plausible dose metric if cell damage is related to some type of physical interference with cell viability.
38
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Critical target organs for ingested copper include the kidney, liver,
spleen, and nervous system (Chen et al. 2006; Prabhu et al. 2009).
Repeated skin application (e.g., via facial spray) could lead to killing of
DRG somatosensory neurons and other nervous system cells as well as
causing residual damage among surviving neurons.
A novel microdosimetric model (Scott 2010) for the cytotoxicity of insoluble nanomaterials is used to assess copper nanoparticle cytotoxicity in
vitro. The mode of cell death is presumed to be via autophagy triggered
by mitochondrial stress (Arciello et al. 2005; Prabhu et al. 2009) related to
uptake (hits) of copper nanoparticles by mitochondria (Salnikov et al.
2007) in the target cell population. Thus, only a single mode of death is
presumed here. Modeling presented elsewhere (Scott 2010) addresses
circumstances involving two competing modes of death: autophagy and
apoptosis. The focus here is on a fixed period of exposure with different
concentrations of MENAP.
METHODS AND RESULTS

The in vitro cytotoxicity modeling carried out is based on the novel
stochastic threshold microdose (STM) model for MENAP-induced cell
killing (Scott 2010). The focus is on insoluble MENAP; thus, particle dissolution is not addressed in the example presented here, but could be
addressed if a variation of the model is developed to include multiple
mechanisms of cell toxicity. In addition, hormetic and bystander effects
(if they occur) are also not addressed. Bystander effects occur when only
some cells (usually a small proportion of the total) but not all take up
MENAP. When the MENAP-free cells also respond (negatively or positively), then it is called a bystander effect.
The STM model as first introduced evaluates the fraction of a target
cell population without lethal damage (survival fraction) after MENAP
exposure of a homogenous cell population for time t. The model is then
modified to apply to a mixed population of hypersensitive and resistant
cells. The present application is based on the specific mitochondrion burden,
Bm(t), of MENAP which is stochastic (i.e., a random variable governed by
the laws of probability) and exposure-time-dependent. The specific mitochondrion burden is the number of particles contained in a single mitochondrion. Thus, the term “specific” is used to denote a single target entity (Scott 2010). The expectation value of Bm(t) evaluated over it’s distribution Ψt(Bm(t)) is formally called the mitochondria burden Mm(t). Thus,
Ψt(Bm(t)) is the probability mass function (pmf), which depends on the exposure time t, the number of mitochondria at risk (which may vary with
time), and can vary for different replicate groups. The terminology “probability mass function” relates to a discrete random variable and corresponds to the probability density function (pdf) which applies to a continuous
random variable. To facilitate initial exploratory analysis of dose-response
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data for MENAP cytotoxicity, it is assumed that Mm(t) increases linearly as
the nanoparticle concentration-exposure-time (CT) product increases for
a limited range for the MENAP exposure considered. Thus, for a fixed
exposure time t = T, Mm(T) = DCFm*CT, where DCFm is the dose conversion factor. The subscript m indicates mitochondria. For the nucleus, the
corresponding factor is therefore DCFn, with the subscript n indicating the
nucleus. The DCFm converts the CT product to average nanoparticle hits
(uptake) to mitochondria among the target cell population.
With the STM model for cell killing as employed here, accumulating
a specific mitochondrion burden (particle count or hits) such that Bm(t)
for a given cell and mitochondrion is greater than a threshold Nm serves
as a marker for triggering the autophagic pathway to death among a homogeneous target cell population. Further, Nm is stochastic (i.e., differs for different cells) and is presumed to depend on the type of MENAP and their
influential biological and chemical characteristics. This allows for influences on Nm of the interactions of MENAP with biological media in the
body and in cell culture (e.g., corona formation).
Because Nm is stochastic (e.g., varying randomly over different cells),
application of the STM model requires assigning a distribution to this
variable. A Poisson pmf (indicated by Φm(Nm)) with expectation value µm
is assumed here (Scott 2010). The reliability of this assumption can be
judged in part on the basis of how well the model performs in characterizing cell survival data.
With the assumed Poisson distribution of Bm(t), one can evaluate the
cell survival probability for a given cell among a large number of cells in
a replicate group. For an individual cell with lethality threshold of Nm
MENAP, the survival probability is given by the Poisson cumulative probability function P(Nm| Mm(t)), which evaluates the probability of not having a value of Bm(t) > Nm (Evans et al. 2000). Accumulating a specific mitochondrion burden Bm(t) = Nm+1 serves as a marker in the STM model for
committing a cell to the autophagic mode of death.
The probability P(Nm| Mm(t)) can be evaluated using the Excel function POISSON(Nm, Mm(t), true) because of the assumption of a Poisson
distribution for Bm(t). When true is replaced with false, Excel is then
informed to evaluate the probability mass for exactly Nm hits to individual
mitochondria.
For many target cells (homogeneous population assumed here) in a
single replicate group, one needs to calculate the expectation (average)
value of P(Nm| Mm(t)) over the distribution Φm(Nm). This leads to the following equation for the replicate-group-specific survival fraction (SF):
SF = P(µm | Mm(t)).

(1)
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In studies involving multiple replicate groups, researchers often average SF over the different replicates. The average SF for a large number of
replicates is then given by the following equation:
E{SF} = P(µm | E{Mm(t)}).

(2)

The notation E{} is used to indicate expectation (i.e., average) value.
An estimate of E{Mm(t)} is the average of the different estimates of Mm(t)
obtained from replicate groups; it can be estimated by fitting Equation 2
to dose-response data for the average SF using the approach indicated
below. The statistic µm as used in Equation 2 should be rounded to the
nearest integer.
Estimates obtained for E{SF} can be used to obtain estimates of both
µm and E{Mm(t)} by fitting Equation 2 to dose-response data while evaluating E{Mm(t)} as equal to E{DCFm}•CT. Care should be taken in selecting
the range of CT over which this approach is used as the relationships may
not hold when large numbers of MENAP are taken up by the target
organelle (which depends on particle and organelle sizes). For example,
there is a physical constraint on the number of MENAP that can be taken
up by organelles such as mitochondria and the nucleus. The estimates
obtained for µm and E{Mm(t)} can then be used along with data for individual replicate groups to evaluate variations in Mm(t) and f over the replicates as is demonstrated below. Bayesian methods (Gamerman 1997;
Gelman et al. 1995) are used to carry out initial model-fitting evaluations.
Less formal methods are then used to investigate variability in model
parameters and dose metrics over replicate groups.
An estimate obtained for µm can then be used along with Φm(Nm)
(which has the single parameter µm) to generate the presumed distribution of Nm. Similarly an estimate obtained for Mm(t) can be used along
with Ψt(Bm(t)) to generate the presumed distribution of Bm(t). The indicated distributions could in theory also be estimated as Hidden Markov
Models (HMM) using replicate groups of cell SF data. The terminology
HMM is used to describe a hypothetical distribution of a presumed real
phenomena that cannot be measured directly but can be inferred via
MCMC analysis when employing Bayesian methods to fit a plausible stochastic model to observable data that relates to the undetectable endpoint (Rabiner 1989); however, evaluating Φm(Nm) and Ψt(Bm(t)) as
HMMs is rather complicated and will need to be addressed in future
research. While the HMM approach was intended to be used in the current paper (Scott 2010), problems encountered with setting up the
MCMC program have not yet been resolved. The HMM approach is, however, used in this paper to obtain estimate of E{ f }, µm, Mm(t). The estimates are evaluated as Bayesian posterior distribution means.
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The modeling described below relates to in vitro killing of DRG
somatosensory neurons by copper nanoparticles, based on data published by Prabhu et al. (2009). Uptake of particles by mitochondria is presumed to increase with time. For the 24-h exposure period considered,
specific mitochondrion burdens at exposure time t = T are initially
assumed to have Poisson distributions with expectation values Mm(T) =
DCFm*CT for a limited range of CT. The DCFm is a free parameter whose
expectation value E{DCFm} can be estimated from dose-response data for
E{SF} as demonstrated below.
In order to use Bayesian methods to apply the STM model to the cytotoxicity data studied, one first needs to assign prior distributions for the
parameters. Ideally, these distributions will bracket the range of possible
values that could apply to a given parameter. Exploratory data analyses
have been used to help with selection of prior distributions for key parameters for the STM model application in this paper as discussed below.
Values for CT are treated as being fixed at their reported values.
Exploratory Analysis Methods

Equation 3 relates to a homogenous population of cells. However, for
circumstances where there is a mixed population of hypersensitive and
resistant cells with the hypersensitive cells being mainly killed, the indicated modeling framework can still be used, with the survival fraction for
the resistant cells set at 1. The in vitro data used here for copper nanoparticle cytotoxicity to DRG somatosensory neurons (Prabhu et al. 2009)
appear to be such a population for the dose range studied (240 to 2400
micromolar-hours). Figure 1 shows results of exploratory analysis of the
indicated data. Cell viability data reported in the paper by Prabhu et al.
(2009) were kindly provided by the researchers (Malathi Srivatsan, personal communications). The overall SF (averaged over replicate groups)
was equated to the proportion of viable neurons (on average) yielding
the middle data set in Figure 1. The average overall SF decreases initially
as CT (in micromolar-hours) increases and approaches an asymptotic
average SF of approximately 0.8. This is interpreted to indicate the killing
of a hypersensitive subpopulation (about 20%), while a resistant subpopulation remains viable. Subtracting 0.8 from these data, setting negative
values to zero, and renormalizing (dividing by E{ f } = 0.2) yields average
SF results presumed to apply to a hypersensitive sub-fraction of neurons.
The parameter f is used throughout this paper to represent the fraction
of target cell population that is hypersensitive and a refined estimate of
it’s expectation value, E{ f }, can be obtained from average SF data using
Bayesian methods as demonstrated below. The average SF for the inferred
resistant cells as presented in Figure 1 is also normalized (data divided by
0.8) so that these data are plotted with the average SF = 1 at all exposure
levels, for the range of exposure levels considered. For higher values of
42
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FIGURE 1. Results of exploratory analysis of SF data (averaged over replicate groups) of rat DRG
somatosensory neurons reported by Prabhu et al. (2009) for in vitro exposure to 70.6 (± 20) -nm copper nanoparticles: overall–data as reported by Prabhu et al.(2009); resist–inferred resistant subfraction
(data normalized for assumed 80% of population); hyper–inferred hypersensitive subfraction (data
normalized to assumed 20% of population).

CT (>> 2400 micromolar-hours), significant killing of resistant cells may
also occur.
The data for hypersensitive cells in Figure 1 can be further analyzed
to provide inferences on the underlying average hits (nanoparticle
uptake) to the critical biological targets (presumed to be mitochondria)
for lethality. Taking the natural logarithm of the average SF for the hypersensitive cells and multiplying the results by -1 gives the hypersensitive cell
lethality hazard function, Hm(t) (Scott 2010); however, Hm(t) only can be
evaluated in this way using dose groups for which not all cells are killed.
The lethality hazard, Hm(t), then can be plotted vs. different dose metrics
(CT, [CT]2, [CT]3, etc.) to infer about the number of hits (on average) to
the critical biological target (mitochondria) for lethality. The metric
yielding an approximate straight line dose-response relationship then
would be inferred as a useful dose metric for the indicated dose-response
data and the power to which CT is raised would be an estimate of the on-average
number of hits (nanoparticle uptakes by the mitochondria) for lethality.
Subtracting 1 from this number then would yield an estimate mu of µm
when mitochondria are the critical target. This approach has been used
to obtain results presented in this paper.
43
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With the estimate mu (= 1 or 2 or 3 etc.) obtained, it then can be used
in the cumulative Poisson probability function P(round{mu}|E{Mm(t)}) to
estimate the value of E{Mm(t)}* that yields a given value of E{SF}. The notation round{mu} means to round to the nearest integer. The ratio
E{Mm(t)}*/CT is an estimate of the average of DCFm, i.e., E{DCFm}. Initial
estimates of E{DCFm}, µm, and E{ f } then can provide guidance for constructing parameter prior distributions for use in Bayesian analysis to
employ the STM model to data.
Figure 2 shows the best results obtained for plotting Hm(t) vs. [CT]n
(for n = 1 or 2 or 3, etc.) and were obtained for n = 2 (implicating mu = 1
for an estimate of µm). The cumulative probability function P(1|E{
Mm(t)}*) then was used to estimate E{Mm(t)}* for the data in Figure 1 for
which CT = 960 molar-hours (lowest nonzero survival fraction level), by
setting the function equal to the average, E{SF} =0.081, for the inferred
hypersensitive sub-fraction and finding the value of E{Mm(t)}* that yielded the desired average SF value. Calculations were carried out using the
Excel Goal Seek algorithm and corresponding Excel cumulative probability function POISSON(1, E{Mm(t)*}, true). This led to an estimate of
E{DCFm} of 0.0043 copper nanoparticle hits (particle uptakes) to mitochondria per micromolar-hour of exposure to copper nanoparticles.

FIGURE 2. Lethality hazard for the inferred hypersensitive subfraction of DRG somatosensory neurons exposed in cell culture to 70.6 (± 20)-nm copper nanoparticles, based on data in Figure 1. The
line was fitted to the highest dose point to see if the low-dose part of the line adequately represented the low-dose data when [CT]2 (in micromolar2-hours2) is used as independent variable.
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Modification of Equation 2 to Allow for Mixed Cell Population

To allow for a mixed population of neurons with a hypersensitive fraction f[1] = f and resistant fraction f[2] = 1 - f, which are assumed to vary over
replicate groups, Equation 1 was modified so that the following applies:
SF =f•P(µm|Mm(t)) + (1 - f).

(3)

When averaged over a large number of replicate groups, one gets the
following which corresponds to Equation 2.
E{SF} =E{ f }• P(µm| E{Mm(t)}) + (1 - E{ f }).

(4)

With the constructs for Equations 3 and 4, none of the resistant cells
are killed. Only the hypersensitive sub-fraction f is presumed to be killed.
Note that setting f = 1 in Equation 3 and E{ f } = 1 in Equation 4 leads to
Equations 1 and 2 which apply to a homogenous population. When
employing Equation 4, µm should be rounded to the nearest integer. For
example, µm = 0.05 should be rounded to 0. Similarly, µm = 1.05 should be
rounded to 1.
Assignments of Prior Distributions for Model Parameters

Based on the above preliminary estimates for E{ f }, µm, and DCFm, and
given the uncertainty associated with this modeling, rather broad prior
distributions were assigned to the indicated parameters for the application of Bayesian analyses to fit Equation 4 to the data in Figure 1 for overall survival (averaged over replicate groups) of DRG somatosensory neurons exposed in vitro to 70.6 (± 20)-nm copper nanoparticles. The prior
distribution assigned to E{ f } was a uniform distribution with min = 0.0001
and max = 1 (brackets the preliminary estimate of 0.2). The prior distribution assigned to µm was uniform with min = 0 and max = 20 (brackets
preliminary estimate mu = 1). The prior distribution assigned for the
DCFm was uniform with min = 0.001 and max = 0.01 (brackets the preliminary estimate 0.0043).
Because of concern for a linear relationship between Mm(t) and CT
not applying for high levels of exposure, only data for the lowest four
exposure levels (CT= 240, 480, 960, and 1440 micromolar-hours) were
used initially in fitting the STM model to the cytotoxicity data. Table 1
shows the dosimetric results obtained with employing WinBUGS (Lunn et
al. 2000) software to implement the STM model based on the data in
Figure 1 for overall survival. The number of killed cells among 1500 neurons at risk per group (Prabhu et al. 2009) was assumed to have a binomial distribution with expectation value 1500(1-E{SF}) and variance 1500(1E{SF})E{SF}. Plating efficiency is not addressed here and this may con45
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TABLE 1. Predicted dosimetric variable values based on the STM model and cell killing data of
Prabhu et al. (2009) for in vitro application of 70.6 (± 20)-nm copper nanoparticles to somatosensory DRG neurons of the rata
Percentile
Endpoint

E{DCFm}b
µm + 1
E{Mm(t)} for CT = 240c
E{Mm(t)} for CT = 480c
E{Mm(t)} for CT = 960c
E{Mm(t)} for CT = 1440c
E{Mm(t)} for CT = 1920c
E{Mm(t)} for CT = 2400c

Posterior
Distribution Mean

Standard
Deviation

2.5%

50%

97.5%

0.0032
2
0.76
1.52
3.05
4.57
6.1
7.62

2.7E-4
1.4
0.065
0.13
0.26
0.39
-

0.0027
0.23
0.64
1.28
2.57
3.85
-

0.0032
1.68
0.76
1.52
3.04
4.56
-

0.0037
5.6
0.89
1.79
3.57
5.36
-

a
Based on Bayesian inference implemented with MCMC using 15,000 iterations (10,000 burn-in)
for lowest four dose groups.
b
Nanoparticle hits (uptake) to mitochondria per unit CT (i.e., micromolar-hours).
c
CT is the copper nanoparticle concentration time product in micromolar-hours.

tribute some systematic error to estimates obtained for model parameters. Also because it was easier to obtain the posterior distribution for “µm
+ 1” (average hits to mitochondria required for lethality) with the
approach used to fit the STM model to data, this is the statistic that is
reported in Table 1.
In addition to µm + 1, endpoints listed in Table 1 are E{DCFm} and
E{Mm(t)} for the different levels of CT in Figure 1. For the MCMC analysis, the zero-dose group (controls) was excluded in order to avoid traps
(stoppage of the program) in the computer code application. Total
MCMC iterations were 15,000 with the first 10,000 results discarded as
burn-in (uninformative data). Autocorrelation results obtained after the
first 5,000 iterations suggested that a single long MCMC chain of 10,000
iterations should be sufficient for convergence. Thus, the 15,000 total
iterations (10,000 burn-in + remaining 5000) used were presumed to be
adequate for the investigations carried out.
The results in Table 1 for the highest two dose levels (1920 and 2400
micromolar-hours) were obtained with a separate MCMC analysis with
E{DCFm} fixed at the posterior mean (0.0032) obtained using only data for
the lower 4 levels. All of the endpoints in Table 1, except µm + 1 had
roughly Gaussian posterior distributions, suggesting that the reported
standard deviations for the indicated distributions may be informative.
However, the posterior distribution for µm + 1 had a mode of about 1–2
and a long tail to the right (departure from Gaussian). The posterior distribution mean and standard deviation for µm + 1 was 2 ± 1.4. The corresponding mean and standard deviation for µm is therefore 1 ± 0.4; essentially the same result as the initial estimate of µm = 1 based on Figure 2.
46
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When all of the six exposure groups were included in the analysis, an
apparently biased estimate µm = 2 was obtained as the posterior distribution mean. The apparent bias is considered to relate to departure from a
Poisson distribution for Bm(t) at high levels of exposure.
The results obtained imply that on average > 1 hit to each mitochondrion at risk is expected to be associated with significant cell killing via
autophagy. For a point of reference, when Mm(t) = 2, then 86% of the
mitochondria population among all target cells would be expected to
have taken up at least 1 copper nanoparticle. Such a large number of hit
mitochondria (those with particle uptake) for an individual cell might be
expected to be sufficient to trigger a severe stress response. Thus, if mitochondria are indeed the critical target, multiple mitochondria may need to
participate in the signaling that leads to the autophagic mode of death.
Table 2 gives the MCMC generated posterior distribution related statistics obtained for the average overall SF (overal1, overall2, ...) and the
average SF for the presumed hypersensitive sub-fraction (hyper1, hyper2, ...)
for the corresponding six levels of the CT product considered (level 1,
TABLE 2. Posterior distribution statistics for the average survival fraction for overall survival and
for the hypersensitive subfraction of somatosensory DRG neurons of the rat exposed in vitro to
70.6 ( ± 20)-nm carbon nanoparticles for 24 h based on the STM model and data of Prabhu et al.
(2009).a
Percentile

Endpoint

Posterior
Distribution Mean

Standard
Deviation

2.5%

50%

97.5%

E{ f }
Hyper1b
Hyper2b
Hyper3b
Hyper4 b
Hyper5 b
Hyper6 b
Overall1 c
Overall2 c
Overall3 c
Overall4 c
Overall5 c
Overall6 c

0.215
0.822
0.551
0.195
0.06
0.021
0.006
0.962 (0.939)d
0.904 (0.94)d
0.827(0.816)d
0.798 (0.796)d
0.787 (0.783)d
0.784 (0.789)d

0.013
0.023
0.043
0.038
0.019
0.025
0.009
0.003
0.0054
0.0057
0.009
0.0076
0.0077

0.192
0.775
0.467
0.129
0.03
0.0021
4.6E-4
0.995
0.893
0.816
0.78
0.773
0.769

0.214
0.823
0.551
0.194
0.058
0.015
0.004
0.962
0.904
0.827
0.798
0.787
0.784

0.244
0.864
0.663
0.274
0.103
0.056
0.017
0.968
0.914
0.838
0.815
0.802
0.799

a
Results for lowest four dose groups are based on Bayesian inference implemented with MCMC
using 15,000 iterations (10,000 bur-in). Results for the highest two dose groups are based on 10,000
iterations (5,000 burn-in).
b
Hypersensitive cell survival statistics for groups Hyper1, Hyper2, ... for the six nonzero dose groups
starting from the lowest to the highest.
c
Overall cell survival statistics for groups Overall1, Overall2, ... for the six nonzero dose groups
starting from the lowest to the highest.
d
Experimentally observed average SF, based on reported average proportion of viable cells
(Prabhu et al. 2009)
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CT = 240 micromolar-hours; level 2, CT = 480 micromolar-hours; level 3,
CT = 960 micromolar-hours; level 4, CT = 1440 micromolar-hours; level 5,
CT = 1920 micromolar-hours; level 6, CT = 2400 micromolar-hours). The
average SF for the presumed resistant sub-fraction was fixed at 1 and therefore no information related to this sub-fraction is provided in the table.
Roughly Gaussian posterior distributions were obtained for E{Mm(t)}
for the four lowest exposure levels. The posterior distribution for the
average fraction (E{ f }) for the hypersensitive cells was also roughly
Gaussian, with a mean of 0.215 and standard deviation of 0.013. The correlation between E{ f } and µm was -0.02. The correlation between E{ f } and
E{DCFm} was - 0.78. The correlation between E{DCFm} and µm was 0.29.
Thus, when employing the STM model using standard Monte Carlo, the
indicated correlations need to be accounted for. Alternatively, one can
rerun WinBUGS exactly as previously used to fit the STM model to the
dose-response data, but this time also making predictions for endpoint of
interest (e.g., E{SF} for new values of CT). This way the correlations will
be automatically accounted for.
Figure 3 gives STM-model-based average survival curves (based on
Bayesian analysis posterior distribution means) for the overall mixed population and for the resistant and hypersensitive sub-fractions plotted as

FIGURE 3. Fitted cell population SF (middle curve; averaged over replicate groups) for DRG
somatosensory neurons exposed in culture for t = 24-h to copper nanoparticles based on data from
Prabhu et al. (2009) and the STM model. The independent variable is the posterior distribution
mean for E{Mm(t)}. Data points are averages of experimental replicates (Prabhu et al. 2009). Also
shown are predicted survival curves (population average) for the inferred resistant (upper horizontal line) and hypersensitive (bottom curve) neuron subfractions. All three curves apply only to 24hour exposure in virto.
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functions of E{Mm(t)}. The average SF values are based on Table 2 and calculated data points were simply connected using Excel’s smoothing function. The experimental data of Prabhu et al. (2009) for the overall SF averaged over replicate groups are also shown in Figure 3. Thus, the smooth
curves in Figure 3 are estimates of the population average SF. The statistics presented in Table 1 also apply to the population average SF.
Figure 4 shows the same curves as in Figure 3 but plotted vs. the corresponding values for the CT product in micromolar-hours. There is close
agreement between the posterior distribution means for E{SF} in Figures
3 and 4 and the experimentally derived average SF data for the presumed
mixed cell population. The maximum difference between the smooth
curve for average overall survival and the data was < 0.05. Almost identical results (not shown) as presented in Table 2 for the average overall survival fraction (posterior distribution mean) was generated using the
Equation 4 with parameters set at their posterior distribution means in
Tables 1 and 2.
DISCUSSION AND CONCLUSIONS

The estimate of 0.215 and standard deviation (0.013 ) for E{ f } in
Table 2 do not apply to individual replicate groups (especially the standard deviation); however, data for individual replicates can be analyzed as
indicated below where individual SF data (43 data points) from replicate
groups of Prabhu et al. (2009) are used. Two judged outliers were excluded. Forty-three different estimates of f were generated based on solving
Equation 3 for f (which applies to a single replicate) with SF replaced by

FIGURE 4. Same curves as in Figure 3 but plotted against CT (micromolar-hours).
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SF*, f replaced by f*, and Mm(t) replaced by Mm(t)* to indicate estimates
of these quantities. This led to the following equation:
f* = (1- SF*)/[1 –P(1| Mm(t)*)].

(5)

Assuming that E{Mm(t)} has a relatively small coefficient of variation,
an estimate E{Mm(t)}* based on averaging over replicate studies can be
used as an initial estimate (to be refined) of Mm(t) in Equation 5. For data
points for which SF* = 1, they were temporarily set to 0.99 when evaluating f* to ensure values > 0 (an assumption). This was especially important
for the lowest exposure group for which CT = 240 micromolar-hours. The
scatter in the value of f* for the different exposure groups were quite similar for all except for the lowest exposure group (CT=240 micromolarhours) as demonstrated in Figure 5. Greater variability is associated with
the exposure group for which CT=240 micromolar-hours, which relates in
part to uncertainty in the observed SF data. The individual data for f*
ranged from 0.03 to 0.62, suggesting considerable biological variability in
the replicate cultures used by Prabhu et al. (2009). The values for f* were
not correlated with CT (R2 = 0.0014, p > 0.5).
Averages of f*and the associated standard deviations by the exposure
group were 0.25±0.26 (CT=240), 0.20 ± 0.16 (CT=480), 0.20 ± 0.08
(CT=960), 0.21 ± 0.06 (CT=1440), 0.21 ± 0.11 (CT=1920), and 0.21 ± 0.1
(CT=2400). Thus, these 6 averages (over replicates) are reasonably simi-

FIGURE 5. Variability in the estimates f* of f (fraction of hypersensitive DRG neurons) plotted vs. the
different values for CT (micromolar-hours) used by Prabhu et al. (2009).
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lar to the posterior distribution mean for E{ f } reported in Table 2 which
is based on fitting the STM model to data for the average SF for the replicates. The un-weighted mean of these 6 estimates and standard error are
0.214 ± 0.021, which are close to the results in Table 2 for the posterior
distribution mean (i.e., 0.215 ± 0.0130). Note also that the standard deviations for each of the 6 estimates above are larger than the standard deviation in Table 2 for the posterior distribution of E{ f }.
The indicated 43 values for f* were used in Equation 3 along with µm
= 1 to find new (refined) values of Mm(t)* that yield the observed values
for SF. Computations were carried out in Excel using the Goal Seek algorithm. One simply finds the value for Mm(t)* that makes Equation 3 corresponded to the desired value for SF*. This led to 43 new estimates for
Mm(t)* which are plotted in Figure 6 (some overlapping). The data in
Figure 6 are correlated with CT (R2 = 0.856, p < 0.001) and show clear saturation (i.e., nonlinear) at high levels of CT. The results obtained suggest
that on average not more than about eight of the 70.6 (± 20)-nm copper
nanoparticle can be taken up by mitochondria of DRG somatosensory
neurons in cell culture. This needs to be verified experimentally.
Unlike the pmf Φm(Nm) which is independent of Mm(t), the presumed
Poisson distribution Ψt(Bm(t)) of Bm(t) changes as Mm(t) changes and
can be displayed using the Excel function POISSON(n, M(t), false), with n
taking on target hit numbers (nanoparticle uptakes) 0, 1, 2, etc. This is

FIGURE 6. Variability in the estimates Mm(t)* of the mitochondria burden Mm(t) plotted vs. the different values for CT (micromolar-hours) used by Prabhu et al. (2009).
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illustrated in Figure 7 where values are assigned to Mm(t) based on the
exposure-group-specific posterior distribution means in Table 1.
Similarly, the distribution (an estimate) of the threshold hits (nanoparticles uptakes), Nm, to be exceeded for lethality can be displayed using the
Excel function POISSON(n, µm, false). This is illustrated in Figure 8 based
on µm having a value of 1.

FIGURE 7. Predicted Poisson distribution probability mass function Ψt(Bm(t)) for the specific mitochondrion burden, Bm(t), for the following predicted values of the mitochondria burdens Mm(t)
based on results in Table 1: Mm1, Mm(t) = 0.76; Mm2, Mm(t) = 1.52; Mm3, Mm(t) = 3.05; Mm4, Mm(t)
= 4.57; Mm5, Mm(t) = 6.1; Mm6, Mm(t) = 7.62.

FIGURE 8. Predicted Poisson distribution probability mass function Φm(Nm) of the number Nm of
mitochondrion hits (nanoparticle uptake) by copper nanoparticles to be exceeded (stochastic
threshold) for triggering presumed autophagic-mode death in hypersensitive DRG neurons in culture when µm = 1 as implicated for the posterior distribution mean of µm + 1 in Table 1.
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The variability in the SF values over replicate groups due to variability in Mm(t) and in f can be addressed in the context of the STM model as
illustrated in Figure 9. The central curve was generated using Equation 3
with parameter value assignments of µm = 1 and f = 0.215. The upper
jagged curve (data points joined by straight lines) is based on the calculated maximum values for SF and the lower curve is based on calculated
minimum values using the different exposure-group specific values for f*
and Mm(t)* in Figures 5 and 6. The parameter µm was fixed at 1, which is
presumed to be a reliable estimate. Thus, the variability was ascribed to
variability in f and Mm(t). It follows that the STM model (as applied here)
not only adequately represents the dose-response curve for the average
survival (Figures 3 and 4) but also provides a plausible explanation of the
variability in SF data over replicate groups (Figure 9). The explanation is
that different values for f and Mm(t) apply to different replicate groups.
Variability in f is biological variability likely related to the cell culture
sample selection process. Variability in Mm(t) likely relates to variability in
the copper nanoparticle particokinetics and may also relate to variability in CT
for a given intended exposure level (e.g., CT = 240 micromolar-hours
intended but CT = 250 micromolar-hours actually achieved for a given
replicate group).
Modeling results obtained indicate that when the average of the specific mitochondrion burden (organelle hits) of nanoparticles exceeds 1
particle per each mitochondrion, significant killing of the inferred hypersensitive subpopulation is expected to occur. When Mm(t) = 2, then 86%

FIGURE 9. Variability over replicate groups in the SF data of Prabhu et al. (2009) for 70.6 (± 20)-nm
copper nanoparticle induced cytoxicity to DRG neurons in culture. The central, upper and lower
curves are based on the STM model as explained in the main text.
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of the mitochondria would be expected to contain at least one nanoparticle. Thus, multiple mitochondria in a given target cell may be involved
in signaling for triggering the presumed autophagic mode of cell death.
Further, the results obtained suggest that there appears to be an upper
limit to the number of copper nanoparticles that can be taken up (possibly < 10) by a given mitochondrion.
If there is a limit on the number of nanoparticles that can be taken
up by a given mitochondrion (e.g., < 10), then the distribution cannot be
Poisson when the mean burden is close to 10. Thus, the distributions presented in Figure 7 may be in error for Mm(t) >> 1. This could be
addressed by truncating the Poisson distribution and reassigning probability mass for specific burdens > than a maximum burden Bm,max into the
probability mass Ψt(Bm,max); however, this issue will have to be addressed
in future research.
The number of hypersensitive DRG somatosensory neurons destroyed
by copper nanoparticles is predicted to increase as the mitochondria burden (average of specific mitochondrion burdens) of nanoparticles increases, as could occur after repeated skin applications of material containing
the particles. Further, the results presented suggest that repeated low-level
exposure (e.g., over years) of humans to copper nanoparticles could eventually lead
to complete destruction of the implicated hypersensitive subpopulation of neurons.
Thus, it is important for researchers to focus on identifying these cells (if
they exist) and identify their functions. In addition, surviving hypersensitive and resistant cells may have dysfunctional mitochondria after moderate and high level exposure to copper nanoparticles which could lead to
nervous system dysfunction and related morbidity.
In circumstances where more than two sub-fractions of cells of varying sensitivity (with sensitivity evaluated as 1/µm) are involved and there
is a single mode of death (autophagic), one can evaluate the contribution
to the overall survival for the jth sub-fraction using f[j]•P(µm[j]| Mm[j]),
where the parameters f[j] and µm[j], and variable Mm[j] correspond to f,
µm, and Mm(t) for a homogenous population of cells. The different subfractions f[j] must however sum to 1 as was the case used here where f[1]
= f (hypersensitive cells) and f[2] = 1 - f (resistant cells).
The relative sensitivity (RS) of a subfraction j relative to a subfraction
k can be evaluated as follows:
RS[j,k] = (1/µm[j])/( 1/µm[k]) = µm[k]/µm[j].

(6)

Even though the critical target modeled here was assumed to be mitochondria, a similar approach would apply if the critical target was the
entire cell, cytoplasm, nucleus or another organelle in the cell that takes
up nanoparticles. For multiple modes of cell killing (e.g., damage to
mitochondria, damage the nucleus, damage to membranes, etc.), an
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approach similar to the approach described elsewhere (Scott 2010) can
be used.
The STM model cannot by itself be applied for in vivo exposure of the
skin to MENAP because exposure of the skin does not necessarily mean
that the particles will reach a target cell population of interest. For in vivo
toxicity assessment, the model has to be coupled with particokinetics (systemic and other transport) and particodynamics (tissue, cell, and organelle
uptake and retention) models. Also, copper nanoparticles tend to agglomerate (Prabhu et al. 2009) and this has not been addressed in the present
application of the STM model. Even so, individual copper nanoparticles
would be expected to be more efficiently taken up by neurons and their
organelles than agglomerates; thus, the mathematical relationships presented would be expected to also apply to individual nanoparticles released
from extracellular agglomerates that entered neurons as single nanoparticles. In addition, the mathematical relationships presented could also be
applied to individual atoms released from extracellular nanoparticles via
dissolution. In this case Bm(t) would represent the number of atoms (e.g.,
copper) contained in a given mitochondrion at exposure time t.
Different research groups sometimes evaluate nanoparticle concentrations using different approaches. Thus, what is reported as a nanoparticle concentration in micromolar units may vary between different
research groups when applying the same amount of material to the same
volume. This will impact on the value derived for DCFm but not on the
microdosimetric spectra generated for Bm(t) using the STM model. This
is because microdosimetric spectra are derived via biological microdosimetry that relates to the observed cell survival fractions.
The title of this paper poses the rather important question: “Are some
neurons hypersensitive to metallic nanoparticles?” While the question has
not been convincingly answered, sufficient indirect evidence is presented
implicating the existence of hypersensitive neurons; thus, there is a need
for more experimental research that directly addresses the question. An
additional question should also now be posed that also relates to new
research needs: Are neurons that survive MENAP hits to the majority of
mitochondria dysfunctional and if so can the dysfunction contribute to
neurological diseases?
While the results presented relate to concerns about skin application
of MENAP, other routes of exposure (e.g., inhalation, ingestion) could
also lead to nervous system damage as well as to damage to other body
organs (e.g., lung, heart, liver, etc.). Further, cells in these other organs
that survive MENAP damage could be dysfunctional and thereby contribute to organ dysfunction and related morbidity. Thus, it is important
that regulatory agencies, nanotechnology organizations, and the general public be aware of these possibilities and institute protective measures
as necessary.
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